Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  BPC-157: What Is It and What Does the Research Say?

BPC-157: What Is It and What Does the Research Say?

Jun 11, 2026 4 min Healing & Recovery
TL;DR
BPC-157 is a 15-amino-acid peptide originally isolated from human gastric juice. Animal studies consistently show faster healing of tendons, muscles, ligaments, and wounds, but human clinical data remains very limited. It is not FDA-approved, and anyone researching it should review dosage data carefully before drawing conclusions.

What Exactly Is BPC-157?

"Peptide" just means a short chain of amino acids — the building blocks of proteins. BPC-157 is one of those chains, made up of 15 amino acids. Scientists first isolated it from human gastric juice, the digestive fluid in your stomach. Its full name is Body Protection Compound 157. Researchers noticed it seemed to help protect and repair stomach lining, then started asking: could it help other tissues too?BPC-157[1]

A 2025 literature and patent review describes BPC-157 as showing "pleiotropic beneficial effects" — that's science-speak for it appears to do a lot of different things — in preclinical (lab and animal) models covering tissue injury, inflammatory bowel disease, and even central nervous system disorders.[1]

Where Does It Come From Naturally?

Your body already makes a tiny amount of this compound. It lives in gastric juice and is thought to help maintain the gut lining. Researchers then created a stable, synthetic version they could study in controlled experiments. That stability — it doesn't break down easily — is one reason scientists find it interesting as a potential therapeutic tool.[4]

What Is Research Studying BPC-157 For?

Tendons, Ligaments, and Muscles

This is where most of the research attention sits right now. A review published in Cell and Tissue Research looked at every available study on BPC-157 and soft tissue. The verdict? Every single study showed positive healing effects for tendons, ligaments, and skeletal muscle — both after direct injuries and after systemic (whole-body) problems.[2] The catch: almost all of those studies used rodents, not humans.

A 2025 systematic review from Hospital for Special Surgery — one of the top orthopedic institutions in the world — combed through 544 articles published between 1993 and 2024. After screening, 36 studies made the cut: 35 were preclinical (animal or lab), and only 1 was a human study.[3] In that human study, 7 out of 12 patients with chronic knee pain reported relief lasting more than six months after a single intra-articular (into-the-joint) injection of BPC-157.[5] Promising — but 12 patients is a very small group.

Wound Healing

Animal research shows BPC-157 speeds up healing of skin wounds, burns, diabetic ulcers, and complex tissue injuries. Researchers believe it works partly by improving blood vessel function and resolving clotting problems that can slow healing.[4] The peptide appears to rapidly switch on gene expression in wound tissue — essentially telling cells to get to work faster.[4]

Angiogenesis — Growing New Blood Vessels

One of the most studied mechanisms is angiogenesis: the process of forming new blood vessels. Tendons and ligaments are notoriously poor healers partly because they have very little blood supply. Research suggests BPC-157 stimulates new vessel growth, which may explain why it helps those hard-to-heal tissues.[6] It appears to interact with vascular endothelial growth factor (VEGF) — a key signal molecule that tells the body to build new vessels.[6]

Growth Hormone Pathways and Inflammation

The 2025 systematic review found that BPC-157 enhances growth hormone receptor expression and reduces inflammatory cytokines — the chemical messengers that drive swelling and pain.[3] Lower inflammation plus better growth signaling is a combination that, in theory, supports tissue repair.

What Does the Evidence Actually Show — Honestly?

  • Animal studies: Consistently positive across muscle, tendon, ligament, bone, and gut tissue.[2][3]
  • Human studies: Extremely limited. One small retrospective study on knee pain exists.[5]
  • Safety: Preclinical studies show no adverse effects across several organ systems, and no lethal dose has been established in animals.[1] However, there is no clinical safety data in humans.[3]
  • Regulatory status: Not approved by the FDA or other major health agencies. It was temporarily listed by WADA in 2022 but is not currently on their banned list.[1]

The bottom line from researchers: the results are exciting enough to warrant serious human trials, but those trials haven't happened yet. The gap between "works in rats" and "proven safe and effective in people" is wide, and BPC-157 hasn't crossed it yet.

Dosage: What Do Researchers Use?

Dosing in animal studies varies by route of administration, body weight, and the condition being modeled. Because protocols differ so much, it's important to look at the actual data rather than generalizations. Our BPC-157 dosage chart breaks down the amounts used in published research so you can see exactly what scientists have studied. You can also use our calculator to explore weight-based research dosing conversions. Remember: these are research figures, not medical recommendations.

Sources

  1. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. — Pharmaceuticals (Basel, Switzerland), 2025. PMID 40005999.
  2. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. — Cell and tissue research, 2019. PMID 30915550.
  3. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. — HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2025. PMID 40756949.
  4. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. — Frontiers in pharmacology, 2021. PMID 34267654.
  5. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. — Alternative therapies in health and medicine, 2021. PMID 34324435.
  6. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. — Current pharmaceutical design, 2018. PMID 29998800.
See the dosage chart — BPC-157
A 15-amino-acid peptide studied for tissue repair, tendon-to-bone healing, and gastrointes
BPC-157

FAQ

Is BPC-157 approved for human use?
No. BPC-157 is not approved by the FDA or any major regulatory agency for medical use in humans. It has been studied extensively in animal models with promising results, but comprehensive human clinical trials confirming safety and effectiveness have not yet been completed. It is currently available only for research purposes.[1]
What tissues has BPC-157 been studied on?
Preclinical research covers a wide range: tendons, ligaments, skeletal muscle, bone, skin wounds, burns, the gastrointestinal tract, blood vessels, nerves, and even the spinal cord. A systematic review found consistent positive outcomes across muscle, tendon, ligament, and bone injury models in animals, with one small human knee-pain study also showing encouraging results.[3]
How does BPC-157 work in the body?
Researchers believe it works through several pathways at once. It promotes new blood vessel growth (angiogenesis), boosts growth hormone receptor expression, reduces inflammatory signaling molecules called cytokines, and activates genes involved in tissue repair. Its ability to improve blood supply is thought to be especially important for tendons and ligaments, which naturally have poor circulation.[6][3]
Are there any known side effects of BPC-157?
Animal studies have not found adverse effects across multiple organ systems, and researchers have not been able to establish a lethal dose in preclinical models. However, there is currently no clinical safety data from human trials. Potential risks also exist from unregulated manufacturing and contamination of commercially available products.[3][1]
For research and educational use only. Not medical advice.